12:00 AM
 | 
Apr 03, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Immune Response preclinical data

IMNR said that its HIV vaccine, which consists of its Remune inactivated gp120-depleted HIV-1 immunogen with incomplete Freund's adjuvant combined with an immunostimulatory...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >